JF
VRCA icon

Jump Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Jump Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,820
Closed -$70.7K – 2293
2023
Q3 		$70.7K Buy
+1,820
New +$92.5K ﹤0.01% 1716
2023
Q2 		– Sell
-2,991
Closed -$194K – 2189
2023
Q1 		$194K Buy
+2,991
New +$181K 0.01% 1330
2021
Q3 		– Sell
-1,647
Closed -$186K – 1534
2021
Q2 		$186K Buy
+1,647
New +$200K 0.02% 891

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Jump Financial's VRCA Position: Q4 2023 in Review

Jump Financial sold out of Verrica Pharmaceuticals (VRCA) in Q4 2023, closing a stake of 1,820 shares — an estimated $70.7K sold.

Jump Financial first reported a position in VRCA in Q2 2021 and held it in 3 quarters. The position peaked at $194K in Q1 2023. 64 funds tracked by Wall St. Rank hold VRCA as of Q4 2023.

  • Jump Financial reported no remaining Verrica Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Jump Financial sold 1,820 Verrica Pharmaceuticals shares in Q4 2023, an estimated $70.7K.
  • Jump Financial first reported a position in Verrica Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Jump Financial's Verrica Pharmaceuticals position peaked at $194K in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.